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Cardiovascular risk  
Objectives: White matter hyperintensities (WMHs) are considered macroscale markers of cerebrovascular burden 
and are associated with increased risk of vascular cognitive impairment and dementia. However, the spatial 
location of WMHs has typically been considered in broad categories of periventricular versus deep white matter. 
The spatial distribution of WHMs associated with individual cerebrovascular risk factors (CVR), controlling for 
frequently comorbid risk factors, has not been systematically investigated at the population level in a healthy 
ageing cohort. Furthermore, there is an inconsistent relationship between total white matter hyperintensity load 
and cognition, which may be due to the confounding of several simultaneous risk factors in models based on 
smaller cohorts. 
Methods: We examined trends in individual CVR factors on total WMH burden in 13,680 individuals (aged 
45–80) using data from the UK Biobank. We estimated the spatial distribution of white matter hyperintensities 
associated with each risk factor and their contribution to explaining total WMH load using voxel-wise probit 
regression and univariate linear regression. Finally, we explored the impact of CVR-related WMHs on speed of 
processing using regression and mediation analysis. 
Results: Contrary to the assumed dominance of hypertension as the biggest predictor of WMH burden, we show 
associations with a number of risk factors including diabetes, heavy smoking, APOE 4/ 4 status and high waist- 
to-hip ratio of similar, or greater magnitude to hypertension. The spatial distribution of WMHs varied con-
siderably with individual cerebrovascular risk factors. There were independent effects of visceral adiposity, as 
measured by waist-to-hip ratio, and carriage of the APOE 4 allele in terms of the unique spatial distribution of 
CVR-related WMHs. Importantly, the relationship between total WMH load and speed of processing was 
mediated by waist-to-hip ratio suggesting cognitive consequences to WMHs associated with excessive visceral fat 
deposition. 
Conclusion: Waist-to-hip ratio, diabetes, heavy smoking, hypercholesterolemia and homozygous APOE 4 status 
are important risk factors, beyond hypertension, associated with WMH total burden and warrant careful control 
across ageing. The spatial distribution associated with different risk factors may provide important clues as to the 
pathogenesis and cognitive consequences of WMHs. High waist-to-hip ratio is a key risk factor associated with 
slowing in speed of processing. With global obesity levels rising, focused management of visceral adiposity may 
present a useful strategy for the mitigation of cognitive decline in ageing.   
1. Introduction 
White matter hyperintensities (WMHs) of presumed vascular origin 
(Wardlaw et al., 2013) are widely recognised as an indicator of poor 
brain health (Wardlaw et al., 2015). Age remains the strongest pre-
dictor for the presence of WMHs. However, the total burden of WMHs is 
higher in individuals with cerebrovascular risk (CVR) factors, like hy-
pertension or hypercholesterolemia. WMHs triple the risk of stroke and 
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double the risk of dementia suggesting they reflect pathological pro-
cesses and are not simply a consequence of ageing (Debette and Markus, 
2010). A number of studies have examined the relationship between 
different CVR factors and total WMH burden (Debette and Markus, 
2010). Hypertension usually emerges as the dominant risk factor 
(Debette and Markus, 2010). Beyond this, it is less clear which risk 
factors are associated with the presence of WMHs in different regions of 
the brain, and with impaired cognition, when controlling for other risk 
factors. In other words, there is not sufficient evidence as to which risk 
factors make an independent contribution to WMH spatial distributions 
across the brain and associated cognitive impairment. This is important 
because it may change the focus of clinical management of risk factors 
beyond control of blood pressure. 
Since the first visual scales attempting to quantify WMH burden 
(Fazekas et al., 1987), it has been recognised that WMHs dis-
proportionately fall within periventricular (PV-WMHs) areas or in deep 
white matter regions (D-WMHs). Classification in this way has proven 
useful because deep and periventricular WMHs have different underlying 
microstructure, different associations with CVR factors (Griffanti et al., 
2018) and potentially different relationships to cognition (Mortamais 
et al., 2013). Although pathology studies are relatively rare compared to 
imaging studies, there is some evidence of different pathological processes 
underlying WMHs in different regions (Wardlaw et al., 2015). PV-WMHs 
are associated with cerebral ischaemia and demyelination of adjacent fibre 
tracts as well as ependymal loss around the ventricles (Fazekas et al., 
1993; Kim et al., 2008). PV-WMHs capping the ventricles are thought to be 
non-ischaemic in nature and reflect more generalised gliosis (Fazekas 
et al., 1998). In contrast, D-WMHs are thought to be of more ischaemic 
origin, the degree of confluence reflecting the degree of ischaemic damage 
with the most severe being marked loss of fibres and arteriolosclerosis 
(Fazekas et al., 1993). The spatial variability of WMHs associated with 
individual CVR factors has been investigated qualitatively using visual 
rating scales or broad region of interest approaches (De Leeuw et al., 2001; 
Strassburger et al., 1997; Van Dijk et al., 2004). There has been much less 
investigation of WMHs at a whole brain level, specifically looking at the 
probability of the presence of WMHs for a given risk factor, voxel-wise. 
Beyond the deep and periventricular classification, there may be im-
portant clues in the spatial distribution of WMHs that explain their pa-
thogenesis and contribution to vascular cognitive impairment. 
There are conflicting reports over whether hypertension, thought to 
be the strongest predictor of total WMH burden, is associated with D- 
WMHs specifically (Moroni et al., 2018; Strassburger et al., 1997) or 
more diffuse WMHs throughout the brain (Moroni et al., 2018; 
Wiseman et al., 2004). Diabetes presents a similarly confused picture in 
the literature. Some reports show no difference in total volume between 
diabetic patients and non-diabetic controls (De Bresser et al., 2018). 
One cross-sectional study showed increased D-WMH volume in diabetic 
patients as well as reduced blood flow. The reduced blood flow may 
explain the pathogenesis of diabetes related WMHs resulting from 
ischaemia in deep white matter (Abraham et al., 2016). Diabetes has 
also been associated with WMH load as a part of metabolic syndrome, 
showing a strong association with subcortical and periventricular 
WMHs (Abraham et al., 2016). However, neither body mass index 
(BMI), nor diabetes appeared to drive this relationship, instead hy-
pertension was the predominant risk factor associated with WMH load. 
Hypertension frequently dwarfs the effects of the other CVR factors, and 
sample sizes are usually too low to examine the individual CVR factors – 
especially because of the high frequency of hypertension as comorbid 
with high BMI, diabetes and smoking. 
The relationship between WMH load and smoking is also incon-
sistent across studies, but has been shown to be an independent risk 
factor, when controlling for age, in 1,814 participants of the 
Framingham Offspring cohort (Jeerakathil et al., 2004). BMI and visc-
eral fat, either measured directly or indexed by waist-to-hip ratio 
(WHR), have also been associated with higher total WMH loads (Kim 
et al., 2017; Lampe et al., 2019b) and shown a preference for deep 
white matter, although this also varies by study (Griffanti et al., 2018; 
Lampe et al., 2019b). Finally, carriage of the apolipoprotein-E (APOE) 
4 allele is associated with higher total volume and higher accumula-
tion of WMHs over time (Sudre et al., 2017), but also shows close in-
terdependence with other CVR factors, such as hypertension (Salvado 
et al., 2019). Examining the independent contribution of the APOE 
4/ 4 genotype to the spatial distribution of WMHs is particularly dif-
ficult in studies with small cohorts, due to the relatively low prevalence 
of this allele in the general population (around 13%). Individual risk 
factors show some interaction with age, for example one large multi- 
centre stroke study in China showed high cholesterol to be a more 
important risk factor in older age (Ryu et al., 2014). Finally, sex appears 
to interact with some of the risk factors, such that the total WMH load is 
higher in females and the predictive risk factors different to males 
(Sachdev et al., 2009). Overall, what emerges from the literature is 
conflicting and complicated associations between individual risk factors 
and the presence of WMHs beyond those associated with age. 
The literature to date has also shown a very mixed picture with re-
gards to the relationship between total WMH load and cognition (Debette 
and Markus, 2010). Where a relationship has been observed, impairment 
to speed of processing and executive function are frequently associated 
with increasing total WMH load. A review of studies between 1990–2013 
investigating the relationship between cognition and WMH load in the 
general population (Mortamais et al., 2013) found equivocal results. Five 
studies found a significant association between WMH load and global 
cognition and two reports failed to find an association (Mortamais et al., 
2013). In studies that have investigated the spatial distribution of WMHs, 
cognitive decline was associated with periventricular WMHs (Godin 
et al., 2010; Prins et al., 2005). It is not clear whether particular risk 
factors increase the likelihood of cognitive decline associated with WMHs 
or whether it is just the total burden of global WMHs that is important. 
The purpose of this study was to use population level imaging, de-
mographic and lifestyle data from the UK Biobank to answer the following 
questions. Firstly, what is the cross-sectional relationship between total 
WMH load and age in the presence and absence of individual risk factors 
at the population level? This serves to clarify overall trends associated with 
the different risk factors and to highlight potential interactions between 
variables such as age and sex. Secondly, our main aim was to investigate 
whether the spatial distribution of WMHs, estimated voxel-wise across the 
whole brain, varied for individual CVR factors? Here, we were interested 
in the contribution of individual risk factors and the spatial distribution of 
WMHs whilst controlling for all other related CVR factors. We extend the 
literature in several ways, by demonstrating quantitative methods to es-
timate the spatial distribution, voxel-wise, and by taking advantage of a 
large sample to examine the unique effects of individual risk factors. 
Finally, we investigated the relationship between individual risk factors 
and speed of processing. We take advantage of a large dataset that enables 
systematic examination of individual risk factors, whilst controlling for 
other risks and a novel method to estimate the probability of CVR-asso-
ciated WHMs at a voxel-wise level. 
2. Methods 
2.1. Participants 
The study was conducted under Biobank application number 34077, 
and imaging data shared within the University of Oxford under appli-
cation number 8107. UK Biobank participants gave written, informed 
consent for the study, which was approved by the Research Ethics 
Committee under application 11/NW/0382. 
Participants were selected according to the flow chart in Fig. 1, 
starting with 22,292 T1 images. Applying the published UK Biobank 
automated processing and quality control pipeline (Alfaro-Almagro 
et al., 2018), 1,985 T1 images were classified as non-usable (for a full 
list of T1 image imperfections see Table 3, Alfaro-Almagro et al., 2018). 
Following the T2 FLAIR pipeline (Alfaro-Almagro et al., 2018), further 
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1,219 participants with T2 FLAIR images missing (incidents during 
acquisition, protocol changes) or non-usable (quality control including 
problems with the acquisition or with the registration to T1) were ex-
cluded, i.e. 20,188 participants with available WMH segmented brain 
images. We excluded data from individuals (590 total) with a current 
diagnosis or history of neurological or neuropsychiatric disease based 
on self-reported, non-cancer illness during a verbal interview with a 
trained nurse. Excluded diagnostic categories were traumatic brain in-
jury, transient ischaemic attack, stroke, haematoma, infection of the 
nervous system, brain abscess, haemorrhage or skull fracture, en-
cephalitis, meningitis, amyotrophic lateral sclerosis, multiple sclerosis, 
Parkinson’s disease, Alzheimer’s disease (AD), epilepsy or alcohol or 
drug dependency (see Table A.1 for a list of excluded participants by 
condition). Given known differences in cardiovascular disease and CVR 
factors between ethnicities (Howard, 2013; Benjamin et al., 2017), and 
the low proportion of non-white individuals in the Biobank cohort (Fry 
et al., 2017), we elected to exclude individuals who self-declared as 
non-white ethnicity (Fig. 1). Participants with missing data and one 
individual with unusually high WMH load (about 12,000 voxels af-
fected by WMHs) were also excluded. As a result, the final dataset for 
the analysis consisted of 13,680 individuals. 
2.2. Cerebrovascular risk factors 
We investigated the main CVR factors known to be associated with 
the presence of WMHs, including hypertension, hypercholesterolemia, 
smoking, diabetes, waist-to-hip ratio and APOE- polymorphism status. 
Using categorical variables for each risk factor (described below), we 
also calculated a cumulative CVR score based on the sum of these 
variables to examine the impact of multiple risk factors on WMH dis-
tribution and its relationship to cognition. We did not use an estab-
lished cardiovascular risk score, such as the Framingham Risk Score 
(Lloyd-Jones et al., 2004), for two reasons. Firstly, the established 
scores typically require continuous measures, such as high density li-
poprotein levels, which were not available in UK Biobank at the time of 
analysis. Secondly, the established scores are typically used to calculate 
the future risk of a cardiovascular event, such as coronary heart disease. 
Here, we were interested in the cumulative effects of multiple CVR 
factors on WMH spatial distribution as well as on cognitive impairment, 
not on the risk of a specific cerebrovascular event. 
Hypertension Blood pressure (BP) was measured using a digital BP 
monitor (Omron), or a manual sphygmomanometer when the digital 
monitor was not available. Two readings were taken moments apart 
and we used the average of these two readings. To increase the relia-
bility of our indicator for hypertension, we included self-reported 
medication for BP as an additional indicator of high BP. Therefore, our 
indicator variable ‘hypertension risk’ had value 1 for anyone (i) with 
average BP measuring over 140/90 mmHg (Boffa et al., 2019) and/or 
(ii) on medication for high BP; otherwise the indicator had value 0. 
Hypercholesterolemia We used medication for cholesterol as an in-
dicator for diagnosed hypercholesterolemia. Participants responded to 
the question “Do you take any of the following medications?” with the 
option of “cholesterol lowering medication” as part of a questionnaire 
presented on touch screen tablets. For those who selected “cholesterol 
lowering medication”, our indicator variable for hypercholesterolemia 
was assigned a value of 1, and 0 for those who answered this question 
but did not select this option. 
Diabetes Diabetes diagnosis was determined from responses to the 
question “Has a doctor ever told you that you have diabetes?”. This 
question was part of a questionnaire presented on touch screen tablets. 
Based on the answer to the question, the indicator variable for diabetes 
was 1 (answer ‘yes’) or 0 (answer ‘no’). 
Smoking Current and past smokers, and non-smokers, were divided 
into groups according to their pack year history. Pack years was cal-
culated as the daily number of cigarettes divided by pack size (20) and 
multiplied by the number of years smoking. The number of years 
smoking was the age at stopping smoking, or the age at testing for 
current smokers, minus the age at which smoking was started. Pack 
years was appropriately adjusted for those who reported giving up 
smoking for more than six months. We grouped participants into non- 
smokers (less than or equal to 10 pack years), smokers (more than 10 
and less than or equal to 50 pack years), heavy smokers (more than 50 
pack years) (Lubin et al., 2016), which resulted in a discrete ‘smoking 
score’ covariate with three levels: non-smoker (0), smoker (1) and 
heavy smoker (2). 
Waist-to-hip ratio Waist circumference is a measure of visceral and 
subcutaneous fat, while hip circumference is thought to represent 
subcutaneous fat only. The ratio therefore represents an elevated pro-
portion of intra-abdominal fat (Shuster et al., 2011). Waist and hip 
circumferences were manually measured in centimeters and used to 
calculate the WHR. The threshold for high WHR was set according to 
the WHO guidelines, set for each sex (World Health Organization, 
2008) (0.9 for males and 0.85 for females). In the subsequent analysis 
we used WHR either as a continuous covariate, or as an indicator of 
Fig. 1. Diagram demonstrating the flow of 
gradually refining participants starting from 
all UK Biobank participants with available 
T1 structural brain images. Most common 
neuropsychiatric/neurological conditions in 
decreasing number of participants: stroke 
(185), transient ischaemic attack (115), 
epilepsy (77), etc. (see Table A.1 for a full 
list). Missingness by risk factor: hyperten-
sion risk (2,075), hypercholesterolemia 
(211), diabetes (165), smoking in pack years 
(3,146), waist-to-hip ratio (413), and APOE- 
status (514). Some individuals have more 
than one of the variables missing; for char-
acteristics of individuals excluded due to 
missingness, see Table A.2. 
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high WHR (1) or not (0). 
APOE- status Carriage of the APOE 4 allele only (not carriage of 
3/ 3 or 2/ 2 or 2/ 3) was considered a cerebrovascular risk factor 
based on a substantial body of research for APOE 4 as a risk factor for 
cardiovascular disease (McCarron et al., 1999) and sporadic dementia. 
The genotyping pipeline is described in full here (Bycroft et al., 2018). 
Based on the number of 4 alleles, a discrete APOE- status covariate 
was created as 0 (no carrier of 4 allele), 1 (heterozygous, i.e. 3/ 4) and 
2 (homozygous, i.e. 4/ 4). 
CVR score The CVR score was created as the sum of the six cate-
gorical variables representing the six risk factors described above: hy-
pertension risk (0/1), hypercholesterolemia (0/1), diabetes (0/1), 
smoking score (0/1/2), WHR (0/1), and APOE- status (0/1/2). The 
resulting composite score was on a scale 0 8 and the higher the score, 
the higher the cerebrovascular burden of an individual. The UK Biobank 
data used to obtain the score are listed in Table A.3. 
2.3. Cognitive testing 
Data from the reaction time task, thought to be a sensitive index of 
speed of processing, was used in the analysis (Fawns-Ritchie and Deary, 
2020). We used speed of processing as a cognitive variable because it 
has most consistently shown a relationship with WMH load, it is nor-
mally distributed and it has considerably less missing data than some of 
the other cognitive test variables available in UK Biobank. The task was 
administered by touch screen at the same session as the MRI scan. The 
UK Biobank reaction time task was a variant of the ‘Snap’ card game, in 
which participants react to the presence of a pair of matching cards 
over 12 rounds of the game. Mean reaction time was recorded and trials 
with responses below 50 ms or above 2000 ms were excluded. 
Education is considered an important confounding variable when 
modelling cognitive function (Evans et al., 1993; Whalley et al., 2004). 
Participants responded to the question “Which of the following quali-
fications do you have?” as part of the questionnaire presented on touch 
screen tablets. A continuous variable “years of education” was defined 
according to the ISCED categories (Lee et al., 2018; Cheesman et al., 
2020); for details see Table A.3. 
Missingness in the cognitive task variable resulted in 923 exclusions 
with further 27 exclusions due to missingness in the education variable. 
Those participants were excluded only when the statistical analysis in-
cluded reaction time as a variable, otherwise 13,680 individuals were used. 
2.4. MRI data 
Volunteers were scanned on Siemens Skyra 3T scanners with 32 
channel head coils. We used the T2-weighted fluid attenuated inversion 
recovery (FLAIR, × ×1.05 1 1 mm resolution) and the T1-weighted, 3D 
magnetization-prepared rapid gradient echo (MPRAGE, × ×1 1 1mm 
resolution, T1 = 880 ms, TR = 2000 ms, matrix = 208x256x256) se-
quence as part of the longer imaging protocol.2 The published UK Bio-
bank pipeline (Alfaro-Almagro et al., 2018) details the spatial normal-
isation procedure of the T1 image to MNI 152 space. Briefly, after 
gradient distortion correction and reduction of the field of view (FOV) to 
remove non-brain space, FNIRT (Anderson et al., 2007) was used for non- 
linear registration to 1 mm resolution MNI 152 space. FNIRT parameters 
were optimised for best performance on the UK Biobank’s T1 image re-
solution and contrast.; the FNIRT configuration file used as part of the UK 
Biobank pipeline is available online at https://git.fmrib.ox.ac.uk/ 
falmagro/UK_biobank_pipeline_v_1/-/blob/master/bb_data/bb_fnirt.cnf. 
All three of the above steps are combined into a single non-linear and 
reversible transformation. Note that participants with large ventricles 
were excluded from the dataset as part of the UK Biobank quality control 
pipeline. After gradient distortion correction, the T2 FLAIR image in 
native space was rigid-body transformed using FLIRT (Jenkinson et al., 
2002) to register to T1 space. We excluded individuals with non-usable 
or missing T1 or T2 FLAIR images, see Section 2.1 and Fig. 1. 
The Brain Intensity Abnormality Classification Algorithm (BIANCA) 
(Griffanti et al., 2016) was used to segment WMHs. BIANCA is an au-
tomated method for WMH segmentation based on voxel intensity and 
distance to the ventricles. BIANCA’s segmentation has been compared 
to segmentation of WMHs from two different cohorts, with different 
MRI sequence parameters, as well as in patient populations (a vascular 
and a neurodegenerative cohort). Correlations in total extracted WMH 
load, spatial overlap and visual rating scales has shown BIANCA to be a 
valid alternative to manual segmentation (Griffanti et al., 2016). When 
applied to the UK Biobank imaging data, it produced an output image in 
subject space which represented the probability per voxel of being a 
WMH; as part of the segmentation, it was then thresholded at 0.8 to 
give a binary WMH mask. The threshold of 0.8 was the optimised 
tuning parameter to minimise prediction error in native space when 
compared to manually segmented lesion masks of 12 UK Biobank in-
dividuals. We applied the estimated spatial normalisation parameters to 
the WMH maps; specifically, the transformation parameters for the T2- 
weighted FLAIR and non-linear warping were used (Andersson et al., 
2007), and then we thresholded the warped WMH maps (the warping 
process used trilinear interpolation that introduced non-binary values) 
at 0.5 to get binary WMH maps in MNI space. The 0.5 threshold was 
used as a neutral value to preference neither enlargement or shrinkage 
of total lesion volume. Having a binary WMH map per participant, we 
estimated the WMH load as the number of WMH-affected voxels. 
All preprocessing steps were performed using the FSL software3. 
Note that voxel size of 2 mm3 was chosen for computational reasons 
and this implied a standard brain mask of dimension × ×91 109 91
voxels. Binary WMH maps and WMH load (unit of measurement was 
2 mm3) were available for 13,680 participants. 
2.5. Statistical analysis 
We chose to do complete cases analysis, rather than impute missing 
data, and therefore excluded 5,338 individuals with missing data in one 
or more CVRs (see Fig. 1 for details). All the exclusions as described in 
Section 2.1 led to a final dataset for the analysis of 13,680 participants. 
2.5.1. Univariate analysis 
From each participant’s WMH binary mask, where one indicates the 
presence of a WMH and zero the absence, respectively, we used the 
subject-specific summary measure log-transformed WMH load as the re-
sponse variable in our first modelling step. Given the highly right-skewed 
distribution of WMH load across the population, we log-transformed 
WMH load to enable the use of standard least squares linear models. 
As an exploratory step of whether and how aging related to log 
(WMH load) in individuals grouped by presence or absence of cere-
brovascular risk factors (or by sex), we used locally estimated scatter-
plot smoothing (loess) (Cleveland et al., 2017) as implemented in R 
package stats, function loess.smooth(). Loess is a non-parametric 
local averaging method, which uses weighted regression inside win-
dows with a fixed number of points. To determine the window, we fixed 
the span parameter to 20%, which means that the horizontal window 
surrounding a target observation contains 20% of its nearest neigh-
bours. Then, a weighted polynomial was fitted to the data within the 
window and the predicted response at the target point was the fitted 
value. The fitted smooth curve provided a graphical overview of un-
derlying patterns in the dataset. We used the resulting fitted curves to 
explore (i) the linear age effect assumption, (ii) the need for an age by 
sex interaction, and (iii) the effect of risk factors on log(WMH load) and 
whether it varied across age. 
2 http://biobank.ctsu.ox.ac.uk/crystal/crystal/docs/brain_mri.pdf. 3 https://fsl.fmrib.ox.ac.uk/fsl/fslwiki 
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Multiple linear regression was used to formally assess the depen-
dence of log(WMH load) on the cerebrovascular risk factors, while 
controlling for known confounders (age, sex, head size). We controlled 
for head size which is a recognised confounding variable in MRI studies 
generally and in UK Biobank specifically (Alfaro-Almagro et al., 2020). 
Because head size correlates with sex, spurious correlations can arise 
between sex and MRI variables if head size is not controlled for. A re-
cent paper on deconfounding UK Biobank MRI data (Alfaro-Almagro 
et al., 2020), recommends the minimal set of confounding variables 
includes age, sex, age-sex interaction and head size scaling (Section 
2.4.1). We also explored the inclusion of an age-sex interaction term to 
the models as one of the confounds. 
With N subjects and Yi the random variable representing the log 
(WMH load) for each subject = …i i N( 1, , ), suppose all Yi ’s are in-
dependent and Normally distributed with means =µ Y( )i i and var-
iance 2, which is the same across subjects. Then a normal linear model 
can be written as 
Y N µ~ ( , ) (random)i i 2 (1)  
= = xY µ( ) (systematic)i i i (2) 
where is an P-vector of parameters, and xi denotes the P-vector of 
subject-specific covariates for subject i and X is the full rank design 
matrix with rows …x x, , N1 . 
To assess the importance of each explanatory variable, maximum 
likelihood estimates (MLEs) of the regression coefficients were explored 
along with 95% confidence intervals (CIs) and p-values (significance level 
0.05). Note that for the discrete explanatory variables (such as sex, hy-
pertension risk, smoking score, etc.), level 0 of the factor variable was 
fitted to be the baseline, e.g. the estimated regression coefficient for hy-
pertension risk estimated the effect of hypertension risk 1 on the outcome 
in comparison to the effect of hypertension risk 0. If the factor variable had 
more than 2 levels, here smoking score and APOE- status, a dummy 
variable was created for each of the two contrasts with category 0 used as 
baseline – category 2 compared to category 0 and category 1 compared to 
category 0 – so two regression coefficients were estimated for the two 
contrasts. We used adjusted R2 (Ra2) as a measure of goodness of fit, which 
is interpreted as the percentage of variance explained. We also computed 
partial Ra2, which measures the additional variation explained by each 
explanatory variable, after adjustment for the other predictors. We fitted 
various multiple regression models aiming to (i) outline the risk factors 
which were significant predictors of log(WMH load), and (ii) to determine 
the models used for the spatial voxel-wise analysis. 
2.5.2. Voxel-wise analysis 
Voxel-wise analysis was employed to assess how different con-
tributors to the cerebrovascular burden related to the spatial distribu-
tion of WMHs. 
Mass-univariate voxel-wise modelling of WMH masks requires a 
generalized linear model (GLM), e.g. logistic regression or probit re-
gression, to account for the binary nature of the WMH masks. Since we 
now want to model WMH probability at each voxel, let Y s( )i j denote a 
Bernoulli random variable with probability of success p s( )i j , where Y s( )i j
represents the presence ( =Y s( ) 1i j ) or absence of a WMH for subject 
= …i i N, 1, , at voxel = …s j M( 1, , )j . Assume …Y s Y s( ), , ( )j N j1 are in-
dependent random variables across subjects i and voxels sj. In contrast 
to the normal linear model, every GLM has a link function g, which is a 
monotonic function that relates the expectation of the random outcome 
to the systematic component. Note that the link function is the identity 




Y s p s p s
g Y s p s s
s s
[ ( ) | ( )]~Bernoulli( ( )) (random)
( [ ( ) | ( )]) ( ) (link)
( ) ( ) (systematic),
i j i j i j
i j i j i j
i j i j
where s( )j is a P-vector of parameters at each voxel sj. 
For this analysis, we have chosen probit link4 1, where indicates 
the standard normal cumulative distribution function, so the model can 
be written as probit regression 
= = xY s s s( ( ) 1 | ( )) ( ( )).i j i j i j
At each voxel sj, we obtain the MLEs s( )j through iterative optimiza-
tion, such as iteratively reweighted least squares (IWLS) (Green, 1984). 
The MLE is the default choice of an estimator due to its optimal 
asymptotic properties. However, in finite samples, the MLE may de-
monstrate significant bias and large variance. Furthermore, in binary 
response models, there is positive probability for the MLE to have at 
least one infinite component, which results in issues with common in-
ference procedures, such as Wald tests and Wald-type CIs. Such infinite 
estimates result when the data are separated (Albert and Anderson, 
1984), that is a covariate or a combination of covariates perfectly se-
parates outcome measurements (e.g. female participants in the dataset 
having a WMH at a particular voxel where no male does). If the MLE is 
infinite, inference becomes impossible and test statistics are unstable. 
Logistic or probit regression has been often used in the voxel-wise 
brain WMH mapping literature (Rostrup et al., 2012; Lampe et al., 
2019b), but potential convergence and bias problems have not been 
discussed to our knowledge. To address both limitations - infinite and 
biased MLEs - we propose the use of test statistics (standardized coeffi-
cients) based on mean bias-reduced (BR) estimates . The bias-correc-
tion approach, which we focused on in the work, was first introduced in  
Firth, 1993 for logistic regression and then further developed for ex-
ponential family GLMs (Kosmidis and Firth, 2009; Kosmidis et al., 2020). 
This method guarantees finite estimates when total separation is ob-
served and it ensures estimates with asymptotically smaller bias than 
what the MLE has. Bias reduction is achieved by subtracting the first- 
order bias in each iteration of the optimization; see Kosmidis and Firth 
(2009) for the exact form of the adjustments. To obtain mean BR esti-
mates, we use the R package Kosmidis, 2020 (Kosmidis et al., 2020), 
which adds additional functionalities to the R function glm(). Note that 
as in the univariate analysis, we chose level 0 as the baseline for factor 
variables, i.e. one regression coefficient was estimated voxel-wise for 
binary explanatory variables and two for discrete variables with three 
levels (level 2 vs baseline (level 0) and level 1 vs baseline), respectively. 
To determine the size of the effect of each explanatory variable, we 
explored test statistics (standardized coefficients or z-scores) based on 
mean BR estimates and their associated p-values. While the mean BR 
estimates ensure better performance when there are few WMH at a 
voxel, like other authors we excluded voxels when the WMH count fell 
too low; for example, Rostrup et al. (2012) and Lampe et al. (2019b) 
required at least 5 participants. Due to the large sample size, we chose 4 
as our threshold, i.e. we only considered voxels where 4 or more par-
ticipants had a WMH (see Appendix B for more details). 
After computing the p-values across the brain, we corrected for 
multiple testing. Threshold-free cluster enhancement (TFCE) (Smith and 
Nichols, 2009) is often used in the literature, but due to the UK Biobank 
sample size of 13,680, TFCE would be computationally expensive to 
perform (c.f. 605 for Rostrup et al., 2012 and 1,825 for Lampe et al., 
2019b, where authors employed the TFCE approach). Instead, we used 
false discovery rate (FDR) correction (Benjamini and Hochberg, 1995), 
i.e. we controlled the expected proportion of falsely rejected hypotheses. 
We favoured FDR over the most common family-wise error rate correc-
tion method, Bonferroni correction, since Bonferroni is known to be quite 
conservative when the comparisons are not independent, which is the 
case for spatially dependent WMH maps (Genovese et al., 2002; Rorden 
and Karnath, 2004). The R function p.adjust() (package stats) was 
used to correct the p-values, using the =FDR 0.05 significance level. We 
4 While logit link is often used, probit and logit links give very similar results 
and we used probit link for comparability with other Bayesian probit-link 
models we investigate. 
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visually inspected axial slices of the standardized coefficients for ‘sig-
nificant’ voxels (voxels where an explanatory variable was a significant 
predictor of WMH risk) to gain understanding of the localized effect of 
cerebrovascular risk factors and how they complemented each other. We 
also inspected the total number of significant coefficients across the brain 
per predictor across a variety of models as a measure of the spread of the 
effect throughout white matter. 
2.5.3. Mediation analysis 
The univariate analysis framework was also employed to explore the 
association between speed of processing (reaction time) and log(WMH 
load) (or CVR score). To better understand the underlying dependencies, 
we also performed mediation analysis to investigate the hypothesis that 
the effect of WMH load on speed of processing (cognitive task) was fully 
or partially explained through a given CVR (mediator); see Fig. A.3. The 
R package mediation (Tingley et al., 2014) was used for the estimation 
and suitable models (GLMs, LMs) were used for the mediator and out-
come models (some of the mediators are discrete variables, which ne-
cessitates the use of GLMs). All models were controlled for age, sex, age 
by sex interaction, head size and years of education. Point estimates 
along with 95% percentile CIs and p-values were explored for the direct, 
indirect and total effects (non-parametric bootstrap, 10,000 resamples). 
We were mostly interested whether the indirect effect was significant, i.e. 
whether there was significant mediation effect, and if so, what was the 
proportion mediated (percentage of total effect) of WMH load on speed 
of processing operating (partially or fully) through the CVR factors. 
3. Results 
We analysed data from 13,680 individuals from the UK Biobank (mean 
age 62.9 ± 7.4 years, 7,236 female). Summary descriptive statistics of the 
UK Biobank sample characteristics are included in Table 1. The UK Biobank 
variables used in the current work are described in Table A.3. 
3.1. Age by sex interactions 
Fig. 2 suggests a positive linear relationship between age and CVR score 
as well as between age and log(WMH load). Males had overall higher cer-
ebrovascular burden than females with no interaction with age (loess curves 
nearly parallel). Log(WMH load) increased with age and the different slope 
of the sex-specific fitted curves suggested a potential age by sex interaction. 
This was further confirmed through a highly significant interaction term 
( <p 0.001) in a linear model of log(WMH load), adjusted for head size and 
total CVR burden ( =R 0.26a2 , Table 2). To understand the effect of sex on 
the log(WMH load), we used the estimated regression coefficients for sex 
and age:sex interaction term (Model U.1) to check how the outcome vari-
able changed. A female participant aged 75 years would be expected to 
have + × = =exp( 0.48 0.01 75) exp(0.27) 1.31-fold higher WMH load 
than a male participant the same age. For a female participant aged 50, we 
get 1.02-fold difference in WMH load, respectively, which highlights the 
effect of the interaction term. We therefore adjusted all subsequent uni-
variate models of log(WMH load) and voxel-wise models of WMH masks for 
an age by sex interaction, something often overlooked in analyses within the 
existing literature. 
3.2. White matter hyperintensity load associated with individual risk factors 
Next, we explored the relationship between log(WMH load) and 
individual CVR factors, including hypertension risk, hypercholester-
olemia, diabetes, smoking, WHR, and APOE- status through fitting 
linear regressions (Table 2) and risk factor specific loess-smoothed 
curves (Fig. 3). Age’s dominant effect was seen here: a 10-year age 
difference was associated with a =exp(0.6) 1.82-fold difference in WMH 
load. All CVR factors had a marked positive effect on WMH load 
(Table 2), with hypertension risk and WHR having the highest partial 
Ra2 (1.7% and 1.2%), e.g. hypertension risk explained 1.7% of the re-
maining variability after adjusting for confounding. The inclusion of the 
CVR score as a predictor led to achieving the highest Ra2 and its partial 
Ra2 of 3.1% resembled the combined effect of the risk factors. 
Hypertension risk was associated with 1.27-fold higher total WMH 
load across all ages ( = 0.24, Table 2; nearly parallel loess curves,  
Fig. 3). The same relationship was observed for diagnosed diabetics 
compared to non-diabetics, with 1.35-fold greater total load across all 
ages for diabetic participants. 
When considering the effects of hypercholesterolemia (medicated 
for high cholesterol) and of high WHR ratio on log(WMH load), the 
loess-fitted curves suggested there might be a risk factor by age inter-
action (Fig. 3). For both risk factors, the log(WMH load) seemed to be 
the same regardless of the risk factor status over the age of 70. Multiple 
linear regression was used to assess the importance of hypercholester-
olemia by age interaction term. A new explanatory variable (multiple of 
the binary hypercholesterolemia variable and age) was added to model 
U.2.2, but there was not enough evidence to reject the null hypothesis 
of no effect ( =p 0.09). The WHR by age interaction was also explored 
(a new term added to model U.2.5) and it was marginally significant 
( =p 0.049). However, the addition of the interaction term did not 
change Ra2 to two decimal places (no higher explanatory power was 
achieved). Thus both interaction terms were not further explored. Both 
hypercholesterolemia and WHR had marked positive effect on log 
(WMH load) (Table 2). 
Table 1 
Characteristics of UK Biobank dataset of 13,680 participants (*12,730 participants for the cognition variable reaction time and education due to missingness). SD: 
standard deviation; WHR: waist-to-hip ratio; APOE: apolypoprotein-E; CVR: cerebrovascular risk; WMH: white matter hyperintensity.      
Characteristics Levels (N) Mean (SD) Median (range)  
Age (years) – 62.9 (7.4) 63.5 (45.1; 80.7) 
Sex Men (6,444), Women (7,236) – – 
Head size – 1.3 (0.1) 1.3 (0.9; 1.8)  
Hypertension risk 0 (7,272), 1 (6,408) – – 
Hypercholesterolemia 0 (10,899), 1 (2,781) – – 
Diabetes 0 (13,017), 1 (663) – – 
Smoking (score/pack years) 0 (11,291), 1 (2,238), 2 (151) 4.9 (11.4) 0 (0; 141) 
WHR (indicator/continuous) 0 (7,251), 1 (6,429) 0.9 (0.1) 0.9 (0.6; 1.2) 
APOE- status 0 (10,226), 1 (3,150), 2 (304) – –  
CVR score 0 (2,596), 1 (4,204), 2 (3,770), 1.7 (1.2) 2 (0; 7)  
3 (1,947), 4 (869), 5 (252),    
6 (36), 7 (6), 8 (0)    
WMH load (2 mm3 voxels) – 528.6 (667.7) 310.0 (3; 8,228)  
Reaction time* (milliseconds) – 585.4 (104.9) 569 (272; 1,559) 
Years of education 7 (780), 10 (1,679), 13 (757), 15 (1,481), 19 (2,027), 20 (6,006) 16.7 (4.3) 19 (7; 20) 
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The highest risk groups for smoking and APOE- status (>50 pack 
years and APOE 4/ 4) were associated with a higher log(WMH load) 
across all ages (Fig. 3). In linear regression analyses, the effect of smoking 
and APOE- status on log(WMH load) was found to be strong and positive 
(Table 2). For example, comparing smoking score 1 to smoking score 0 
(baseline) was associated with =exp(0.15) 1.16-fold increase in WMH 
load, and 1.57-fold increase when comparing 2 to 0, respectively. 
3.3. Spatial distribution of white matter hyperintensities 
We plotted WMH incidence, voxel-wise, across 13,680 healthy 
ageing individuals and reveal the expected spatial distribution of 
WMHs. The highest probabilities were concentrated around the peri-
ventricular areas and in deep white matter regions (Fig. 4). 
Next, we explored the effect of head size, age and sex, and their inter-
action on WMH probability (Fig. 5) since they all act as confounding effects 
when considering the spatial distribution of WMHs associated with in-
dividual risk factors. The figure represents the standardized coefficients (z- 
scores based on mean BR estimates) for voxels which are significant (5% 
FDR correction applied) and have WMH incidence of at least 4 people 
(40,001 voxels, i.e. all other voxels are plotted as transparent). The age 
effect on WMH probability is dominant and widely spread through white 
matter. Also, note that the direction of the effect for those confounding 
variables is the same as in the univariate regression (Model U.1, Table 2), 
i.e. positive (red) for age and age by sex interaction, negative (blue) for sex 
and head size, but with varying effect size across the brain. 
We also explored the effect of each risk factor on WMH probability 
(marginal models, Fig. 6(b)) as well as the contribution of each risk 
factor while controlling for all other risk factors (joint model, Fig. 6(a)). 
On those axial slices, the darker the colour, the stronger the effect of the 
presence of the risk factor when compared to its absence. To quantify 
the WMHs associated with each risk factor, we estimated the percen-
tage of significant voxels in a mask of 40,001 voxels for each risk factor 
in the marginal models and the change in the joint models, when other 
risk factors are controlled for (Table 3). This provided an additional 
measure of the relative importance of the different risk factors. The 
widest spatial distribution, in both periventricular and deep white 
matter, was for hypertension risk – thought to be the strongest risk 
factor, after age, for the presence of WMHs (Fig. 6, Table 3). 
In terms of spatial extent, WHR and APOE 4/ 4 genotype stand out as 
the next notable risk factors with a unique spatial distribution, independent 
of other risk factors. The contribution of APOE 4/ 4 genotype persists re-
gardless of the inclusion of the other risk factors in the model (significantly 
affecting about 4% of the voxels analysed, Table 3). We further plotted the 
APOE 4/ 4 effect and found it was associated with WMH load concentrated 
at the boundary of the occipital and temporal lobes (Fig. A.1). While the 
Fig. 2. Sex-specific trends in CVR score (left) and in log(WMH load) (right) across age. Solid lines represent the loess-smoothed curve with a span of 20% and the 
points are the observed data points. Males have higher CVR burden than females across all ages and log(WMH load) increases across age for both sexes but potentially 
at different speed for males and females. *uniform noise U(0, 1) added to the CVR scores to disperse the values in the y-axis direction (left plot).. 
Table 2 
Univariate regression summaries outlining the association between log(WMH 
load) and cerebrovascular risk factors (or composite score). For all CVRs, the 
presence of the risk has a strong positive effect on log(WMH load) when 
compared to its absence (discrete risk equals 0), e.g. participants who have high 
WHR are expected to have 0.22-fold higher log(WMH load), or 
=exp(0.22) 1.25-fold higher WMH load, than those who do not. Model U.1: all 
predictors in the model shown. Model U.2.1 - U.2.6: main effect of interest 
shown. All models adjusted for age, sex, head size, age-sex interaction and only 
one of the risk factors included in the model. stands for the maximum like-
lihood estimate of the regression coefficient ; two regression coefficients for 
discrete variables with more than two levels (models U.2.4 and U.2.6): con-
trasting level 1 to level 0, and level 2 to level 0 (level 0 modeled as baseline).       
Model/Predictor (level) Estimate 95% CI p-value Ra2/ partial 
Ra2
Model U.1    0.260 
Intercept 2.19 (1.93; 2.46) <0.001
Age 0.06 (0.05; 0.06) <0.001 0.093 
Sex (Female) −0.48 (-0.74;  
−0.22) 
<0.001 0.001 
Age:Sex (Female) 0.01 (0.01; 0.01) <0.001 0.002 
Head size −0.29 (-0.45;  
−0.13) 
<0.001 0.001 
CVR score 0.14 (0.13; 0.15) <0.001 0.031  
Model U.2.1    0.249 
Hypertension risk (1) 0.24 (0.21; 0.28) <0.001 0.017  
Model U.2.2    0.240 
Hypercholesteromia (1) 0.17 (0.13; 0.21) <0.001 0.005  
Model U.2.3    0.240 
Diabetes (1) 0.30 (0.22; 0.37) <0.001 0.005  
Model U.2.4    0.240 
Smoking score (1) 0.15 (0.11; 0.19) <0.001 0.006 
Smoking score (2) 0.45 (0.30; 0.59) <0.001
Model U.2.5    0.245 
Waist-to-hip ratio (1) 0.22 (0.15; 0.25) <0.001 0.012  
Model U.2.6    0.237 
APOE- status (1) 0.05 (0.01; 0.08) 0.011 0.002 
APOE- status (2) 0.23 (0.13; 0.34) <0.001
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Fig. 3. Cerebrovascular risk factor specific trends in log(WMH load) across age. Solid lines represent the loess-smoothed curve with a span of 20% and the points are 
the observed data points. The presence of any of the risk factors suggests higher log(WMH load). Crossing fitted curves would suggest a potential risk factor by age 
interaction and parallel line its absence, respectively. WMH: white matter hyperintensity; WHR: waist-to-hip ratio; APOE: apolypoprotein-E.. 
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spatial distribution of WMHs associated with WHR was concentrated on the 
periventricular areas and had a similar distribution to diabetes positive 
status. Notably, when examining the unique contribution of the risk factors 
(Fig. 6(a)), diabetes was much reduced in spatial extent (drop from 8.2% in 
the marginal model to 1.5% in the joint model), suggesting its contribution 
typically seen in the literature may be confounded by other CVR factors. 
Hypertension, APOE- status and WHR remained important risk factors, even 
after controlling for other CVRs (Fig. 6(a), Table 3). 
The estimated effect of the composite variable CVR score on WMH 
probability (Fig. 5) reflected the combined but varied effect of its 
constituent risk factors (Fig. 6(a)). 
Additional analyses were run to ensure our WHR findings were not 
driven by associated hypertension, using continuous WHR and systolic 
BP (as opposed to binary indicators used in the main analysis). We 
investigated whether the spatial distribution of WMHs is independently 
affected by WHR and systolic BP. Fig. A.2 shows the WHR effect is 
wider in terms of spatial extent with more spatially spread unique ef-
fects in deep white matter (Fig. A.2(d)). 
3.4. Cerebrovascular risk and speed of processing 
Univariate linear regression estimated the relationship between log 
(WMH load) and speed of processing (reaction time in the ‘Snap’ task 
(Table 4). Log(WMH load) was strongly associated with reaction time 
( =p 0.009). The association between CVR score and reaction time did 
not appear to be significant after adjusting for confounding. A model 
including total CVR burden along with log(WMH load) showed only log 
(WMH load) to be a significant predictor of reaction time ( =p 0.011) 
but no explanatory power was gained (Ra2 did not change). 
Next, mediation analysis was used to determine whether any of the 
CV risks could explain the relationship between speed of processing and 
log(WMH load). Mediation analysis (Table 5) found WHR to be the only 
CVR factor to have a significant mediation effect (for the other risk 
factors, see Table A.4). Our results suggested 21% (9%; 83%) of the total 
effect of log(WMH load) on reaction time is explained through WHR. 
4. Discussion 
4.1. White matter hyperintensity associated with individual risk factors 
Population level brain imaging, lifestyle and demographic data on 
13,680 healthy ageing volunteers were used to systematically in-
vestigate the association of cerebrovascular risk factors with the total 
burden and voxel-wise spatial distribution of WMHs. Contrary to pre-
vious reports, which typically emphasise hypertension as the main risk 
factor associated with WMH load, other cerebrovascular risk factors, 
including high waist-to-hip ratio, had similar or higher magnitude as-
sociation with WMH burden, a unique spatial distribution and an in-
dependent relationship with cognition. 
The contribution of known cerebrovascular risk factors to total 
WMH burden was examined. All CVR factors were found to be sig-
nificant predictors of WMH load, motivating our exploration of the 
spatial distribution of the individual risk factors. Previous work in a 
subset (N = 9; 722) of the UK Biobank cohort has shown independent 
contributions of hypertension, diabetes, WHR and smoking pack years 
to the total WMH load (Cox et al., 2019). We replicate this finding, 
showing an additional risk of homozygous APOE 4 status and hy-
percholesterolemia in a larger cohort with complete data. Hypertension 
is frequently found to be the most predictive risk factor for total WMH 
load and therefore management of blood pressure is recommended to 
reduce both the total burden and the progression of WMHs (Verhaaren 
et al., 2013). There was a higher main effect size associated with the 
presence of diabetes compared to hypertension with the former asso-
ciated with a 1.35-fold increase in total WMH burden compared to 
1.27-fold increase for hypertension. However, risk factors including 
heavy smoking, APOE 4/ 4 status and WHR had associations of similar 
magnitude, or greater, than hypertension. We found the presence of risk 
factors associated with higher total WMH load across all ages from 
45–80 (Knopman et al., 2001; Debette et al., 2011). Together this points 
to the need for careful management of multiple risk factors across 
ageing for the preservation of brain vascular health. 
Fig. 4. Square root transformed empirical WMH probability based on binary WMH masks of 13,680 UK Biobank individuals; axial slices =z {35, 40, 45, 50} shown 
(from left to right). Square root transformation leads to more dispersed values allowing for better visualisation. Voxels with three or fewer individuals having a WMH 
are plotted as transparent to show a standard anatomical MRI for reference. 
Fig. 5. Significance maps (z-scores based on mean bias-reduced estimates) for model S.1, which includes age, sex (baseline men), age-sex interaction and head size 
and cerebrovascular risk (CVR) score as explanatory variables. Data on 13,680 UK Biobank individuals, and voxels with at least four individuals having a WMH 
explored (i.e. 0.03% WMH incidence); 5% FDR correction applied; axial slice =z 45 shown. 
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Fig. 6. Significance maps (z-scores based on mean bias-reduced estimates) for (a) model S.2 (joint) and (b) models S.3.1 – S.3.6 (marginal). All models include the 
same confounding variables as models S.1 (age, sex (baseline men), age-sex interaction and head size). Data on 13,680 UK Biobank individuals, and voxels with at 
least four individuals having a WMH explored (i.e. 0.03% WMH incidence); 5% FDR correction applied; axial slice =z 45 shown. 
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A descriptive profile of this ageing population revealed overall higher 
cerebrovascular risk score (i.e. sum of risk factors) in males than females 
from mid through to late life. In terms of total WMH load, males and fe-
males had similar levels that increased linearly until age 65, after which 
total WMH load is higher in females. Several epidemiological studies cor-
roborate this sex effect, with women appearing to consistently have a higher 
total WMH load than men (Sachdev et al., 2009). The age at which the 
difference in total WMH diverges between males and females has varied 
across studies, likely the result of limited sample sizes and age ranges within 
cohorts. One of the largest studies of WMH prevalence, the Rotterdam 
sample of healthy adults aged 60–90 (De Leeuw et al., 2001) found no sex 
differences in total WMH load, but did find sex differences across all dec-
ades in frontal periventricular WMH load (De Leeuw et al., 2001). As well as 
lower resolution scans (1.5 T) and a lower population size (N = 1; 077) 
compared to ours (3T and =N 13, 680), the study used a qualitative rating 
scale based on anatomical landmarks. Here, we used an objective method 
and voxel-wise test statistics across the whole brain to show sex effects and a 
sex by age interaction in 13,680 individuals concentrated in periventricular 
regions, with increased load in females over 65. This finding is important, 
given the higher risk of dementia associated with WMH burden and the 
higher prevalence of dementia in women. Notably, total CVR is higher in 
men of all ages, suggesting the increased WMH load seen in women aged 
over 65 may not be driven by cerebrovascular risk factors (or at least not the 
dominant risk factors included in our study). There is some evidence of a 
genetic component to WMHs, with higher heritability in women (Atwood 
et al., 2004; DeCarli et al., 1999). Another prominent hypothesis for higher 
total WMH load in women suggests the influence of sex hormones, parti-
cularly around menopause may be important. It is not yet known whether 
the higher incidence of AD in women is a risk or result of increased WMH 
load. Longitudinal data in UK Biobank (both imaging data and health out-
comes) may help to establish if the increased WMH load in older women is 
associated with higher incidence of dementia. 
4.2. The spatial distribution of individual cerebrovascular risk factors 
To date, the majority of studies have examined either total WMH 
load or deep versus periventricular WMHs associated with cere-
brovascular risk factors. Where voxel-wise analyses have been at-
tempted, this has either been using logistic regression (Lampe et al., 
2019b), which we have discussed produces unstable test statistics or 
other “ad hoc” methods (Lampe et al., 2019a), but have not examined 
independent cerebrovascular risk factors voxel-wise. 
Examination of the spatial distribution of individual cerebrovascular risk 
factors, led to several important findings. There were unique spatial patterns 
for certain risk factors and it was possible to quantify the contribution of 
different risk factors to total WMH load. Hypertension, WHR and APOE 4
homozygosity emerge as the dominant risk factors in terms of the spatial 
extent of the probability of WMHs and the number of significant voxels after 
controlling for head size, age, sex and their interaction. However, both 
hypercholesterolemia and diabetes did not reveal consistent patterns of 
spatial distribution in models controlling for the other risk factors, despite 
the latter being an important predictor of total WMH load. The finding 
suggests these risk factors may interact with other risk factors such as hy-
pertension and do not present a direct path to the pathogenesis of WMHs. 
The homozygous 4 genotype was revealed to be a significant pre-
dictor of WMH load. The finding is consistent with evidence of increased 
WMH volume in 4 carriers in the UK Biobank cohort and longitudinal 
evidence of WMH progression associated with the 4 genotype (Cox et al., 
2017). Here we also replicate the finding from Lyall et al., 2019, in which 
there is no age interaction observed with APOE 4 status in terms of total 
WMH load, contrary to some reports that APOE 4 effects are most pro-
minent in older age (Schiepers et al., 2012). Importantly, we extend these 
findings to show the spatial distribution of WMHs uniquely associated 
with the APOE 4/ 4 genotype is concentrated in posterior deep white 
matter around the intracalcarine sulcus and extending superiorly into the 
temporal lobes. As evidence of the utility of our method, these in-
dependent effects of APOE 4/ 4 status associated with WMHs in the deep 
white matter of the temporal-occipital lobes would not have been obvious 
with an approach examining only periventricular versus deep WMHs. The 
proximity of these WMHs to the medial temporal lobe is notable, given the 
susceptibility of this region to atrophy and disruption in AD. Given the 
association between APOE 4 and dementia risk, it raises the question as to 
the potential contribution of WMHs to this risk. Longitudinal data is re-
quired to understand whether these WMHs have a role in the development 
Table 3 
Percentage and number of significant voxels across predictors for joint model 
S.2 (all CVR factors) and for marginal models S.3.1 – S.3.6 (one of the CVR 
factors). Note that for factor variables with more than two levels (smoking score 
and APOE- status), level 0 is used as a baseline and we estimate the effects of 
level 1 and level 2 relative to baseline. All models include the same confounding 
variables age, sex, age-sex interaction and head size; Voxels with at least four 
individuals having a WMH explored (40,001 voxels in the brain mask) and 5% 
FDR correction applied, i.e. % FDR-corrected voxels is out of a total of 40,001 
voxels. Columns 2 and 3 complementary to Fig. 6(a) and (b), respectively.     
Predictor (level) FDR-corrected voxels % (voxel count)  
Joint model (S.2) Marginal models (S.3.1-S.3.6)  
Hypertension risk (1) 11.8% (4,705) 13.4% (5,366) 
Hypercholesteromia (1) 0.02% (10) 1.6% (648) 
Diabetes (1) 1.5% (607) 8.2% (3,270) 
Smoking score (1) 0.3% (133) 1.6% (636) 
Smoking score (2) 1.1% (424) 4.1% (1,633) 
Waist-to-hip ratio (1) 4.6% (1,841) 10.7% (4,297) 
APOE- status (1) 0.0% (0) 0.0% (0) 
APOE- status (2) 4.2% (1,708) 3.9% (1,549) 
Table 4 
Univariate regression summaries outlining the association between the cogni-
tion variable reaction time (as outcome) and log(WMH load) and CVR score (as 
explanatory variables). Model U.3.1 – U.3.3: main effects of interest shown. All 
models adjusted for age, sex, head size, years of education and age-sex inter-
action. stands for the maximum likelihood estimate of the regression coef-
ficient .       
Model/Predictor Estimate 95% CI p-value Ra2/partial Ra2
Model U.3.1    0.088 
log(WMH load) 2.55 (0.63; 4.47) 0.009 <0.001
Model U.3.2    0.088 
CVR score 0.96 (−0.57; 2.50) 0.219 <0.001
Model U.3.3    0.088 
log(WMH load) 2.42 (0.47; 4.36) 0.015 <0.001
CVR score 0.63 (−0.93; 2.18) 0.431 <0.001
Table 5 
Mediation analysis. A significant proportion of the log(WMH load) (X) effect on 
speed of processing (Y) is explained through WHR mediation (mediator M). 
Models (mediator and outcome) are controlled for age, sex, age-by sex inter-
action, years of education and head size. See diagram A.3 for an illustration of 
the mediation analysis. stands for the maximum likelihood estimate of the 
regression coefficient .      
Average effect WHR (continuous)  
Estimate 95% CI p-value  
X on M 0.11 (0.10; 0.13) <0.001
M on Y 0.05 (0.03; 0.08) <0.001
Mediation effect 0.005 (0.003; 0.010) <10 15
Direct effect 0.020 (0.0003; 0.040) 0.046 
Total effect 0.025 (0.006; 0.040) 0.010     
Proportion mediated 0.212 (0.089; 0.830) 0.010 
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or increased risk of dementia. Future studies would benefit from applying 
this voxel-wise method to examine how medial temporal lobe networks 
are impacted in the presence of WMHs in this region. 
Waist-to-hip ratio above a healthy, sex-specific threshold, emerged as a 
critical risk factor for management in ageing. There was an independent 
spatial distribution of WMHs associated with WHR, that was not explained 
by comorbid hypertension, and was concentrated in the deep white matter 
and the ventricular caps. WHR was also the only risk factor to show a 
mediation effect on the relationship between speed of processing and total 
WMH burden. Waist circumference has been shown to be a reliable sur-
rogate of visceral adiposity (Onat et al., 2004), and WHR is an especially 
useful measure in an ageing population because intra-abdominal fat tends 
to increase with age, whereas subcutaneous fat increases with degree of 
obesity but not age (Seidell et al., 1988). Cox et al. (2019), also noted an 
independent contribution of waist-to-hip ratio to WMH volume and sug-
gest there may be metabolic and endocrine contributions to the patho-
genesis of these WMHs that is distinct from arterial stiffness associated 
with high body mass (Cox et al., 2019). The dominance of WMHs asso-
ciated with waist-to-hip ratio in deep white matter points to a possible 
ischaemic pathogenesis. Previous work examining deep versus periven-
tricular WMHs associated with visceral obesity also found increased 
probability of WMHs in deep white matter associated with raised levels of 
proinflammatory cytokines (Lampe et al., 2019b). Proinflammatory cyto-
kines are elevated in obesity and have been associated with cognitive 
decline and neurodegenerative processes associated with dementia (Pasha 
et al., 2017). This may help to explain the observed relationship to speed 
of processing we found with mediation analysis. 
Here, we introduce a voxel-wise method that enables plotting the 
probability of the presence of WMHs associated with different risk 
factors or variables such as cognitive scores or symptoms such as de-
pression or anxiety. The existing literature provides a confusing picture 
relating different cerebrovascular risk factors to the location of WMHs, 
and this is largely due to different classifications of lesion locations, 
either total load, separated into periventricular versus deep WMHs or 
divided between lobes or tracts. Our method provides a quantitative 
approach that can be used to standardise how WMHs are spatially 
identified across the brain. Our method has several applications, be-
cause of the granularity of spatial localisation that can be produced at a 
voxel-wise level. For example, future studies might integrate voxel-wise 
results with other imaging modalities to examine how structural or 
functional networks are impacted by WMHs in specific regions. 
4.3. The relationship between risk factors and cognition 
Reductions in speed of processing have been most frequently associated 
with total WMH load, but it is not clear if all WMHs contribute to this 
impairment or whether particular risk factors are implicated. It is now 
widely accepted that cognition is reliant on distributed brain networks. The 
spatial distribution of WHMs may therefore directly impact particular brain 
networks resulting in the observed cognitive deficits. Different risk factors 
may increase the likelihood of WMH in certain regions and therefore de-
ferentially impact cognition. The conflicting evidence in the literature, as to 
whether WMHs do, or do not, correlate with cognitive performance may be 
in part due to conflation of WMHs associated with different CVR factors 
which present different spatial profiles. Beyond the spatial distribution, the 
contribution of individual risk factors to cognitive decline, controlling for 
dominant risk factors like hypertension, may inform clinical management 
strategies. In our analysis, WHR in particular showed a mediating effect on 
the relationship between speed of processing and total WMH burden. Future 
studies might profitably examine the longitudinal relationship between 
visceral adiposity and cognition to assess its importance as an early marker 
of cognitive decline. It is important to note that the explanatory power of 
the cognition models was relatively low which explains the magnitude of 
the regression coefficients, e.g. a change of 1 in log(WMH load) would only 
increase reaction time by 2.8 ms, which is a significant effect but potentially 
not clinically meaningful. 
4.4. Limitations 
Our findings should be interpreted in light of some limitations in the 
data used and biases existing within our cohort. There are limits to the 
conclusions that can be drawn from cross-sectional data, but the benefit of 
the cohort is a very large population size with a wide age range. 
Longitudinal studies are often limited in the age range and number of 
individuals that can be feasibly sampled over time. We used outputs from 
the UK Biobank pipeline for the estimation of WMHs. This pipeline did not 
directly account for ventricular size. Ventricular size is known to increase 
with age and so may affect segmentation of periventricular WMHs in older 
individuals. Nevertheless, the UK Biobank pipeline has a number of quality 
assurance steps to exclude individuals with large structural deviations 
(such as overly enlarged ventricles) and ensure accuracy of normalisation 
processes (Alfaro-Almagro et al., 2018). Due to sampling biases within the 
UK Biobank cohort (Fry et al., 2017) and our decision to exclude non- 
white individuals, our sample is limited in its generalisability to other 
ethnicities and sociodemographic groups. The UK Biobank sample is 
known to be generally healthier with higher socioeconomic status than the 
general UK population. To a certain extent, it is interesting to see effects of 
cerebrovascular risk factors in a relatively healthy cohort, and the effects 
in the general population may be much more pronounced. We were 
somewhat limited in the measurements we could use to represent different 
risk factors, with the majority being categorical variables. Continuous 
measure may have shown increased sensitivity. For example, WHR is a 
reliable surrogate marker of visceral adiposity (Onat et al., 2004) that is 
sensitive to age and metabolic syndromes (Seidell et al., 1988; Shuster 
et al., 2011), however it lacks the precision of CT or MRI for highly specific 
and comprehensive assessment of intra-abdominal fat. Future studies 
should assess intra-abdominal directly with CT or MRI. UK Biobank has 
collected such data but it was unavailable at the time of analysis. 
4.5. Conclusion 
Our findings have some important clinical implications that may 
impact the management of cerebrovascular risk factors. We show the 
relative importance of different cerebrovascular risk factors in the 
contribution to total white matter hyperintensity burden in healthy 
ageing and the varied spatial distribution of CVR-related WMHs across 
the brain. Contrary to the assumption of hypertension as the dominant 
risk factor associated with WMH load, we show the associations of si-
milar magnitude with APOE 4/ 4 status, WHR, diabetes and heavy 
smoking. Independent and unique spatial distributions of WMHs asso-
ciated with high WHR and APOE 4/ 4 status point to careful man-
agement and observation of these risk factors. 
Waist-to–hip ratio above healthy, sex-specific thresholds emerged as 
a key risk factor associated with WMHs in deep white matter and 
ventricular caps. There was some evidence of cognitive consequences to 
WHR-associated WMHs suggesting visceral adiposity, as indexed by 
WHR, represents a risk factor for close clinical management for miti-
gation of cognitive decline in healthy ageing. 
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Appendix A. Complementary tables and figures 
See Tables A.1–A.4 and Figs. A.1–A.3. 
Table A.1 
List of codes of the UK Biobank Data-field ‘Non-cancel illness’ ( http://biobank.ndph.ox.ac.uk/showcase/field.cgi?id= 
20002) used for exclusion of participants in the data cleaning process. 616 illnesses reported across 590 participants.     
Coding Description Number of participants  
1081 Stroke 185 
1082 Transient ischaemic attack 115 
1083 Subdural haematoma/haemorrhage 6 
1086 Subarachnoid haemorrhage 10 
1240 Neurological injury/trauma 0 
1243 Psychological/psychiatric problem 0 
1244 Infection of the nervous system 0 
1245 Brain abscess/Intracranial abscess 0 
1246 Encephalitis 2 
1247 Meningitis 55 
1258 Chronic neurological problem 0 
1259 Motor Neuron Disease 2 
1261 Multiple Sclerosis 62 
1262 Parkinson’s disease 36 
1263 Dementia/Alzheimer’s disease/Cognitive 
impairment 
9 
1264 Epilepsy 77 
1266 Head Injury 14 
1408 Alcoholism 10 
1409 Opioid dependency 0 
1410 Other dependency 0 
1434 Other neurological problem 6 
1491 Brain haemorrhage 10 
1583 Ischaemic stroke 1 
1626 Fracture skull/head 16 
Table A.2 
Characteristics of UK Biobank dataset on 5,338 participants, who were excluded from the analysis due to missingness (*6289 participants for the cognition variable 
reaction time and years of education). There does not seem to be systematic differences between the two datasets, so the exclusions are not likely to have introduced 
some bias in the results of the analyses. Similar to Table 1 with an additional column summarising the number of missing values for each variable. Summaries 
calculated without missing values for each variable. The percentage values under each discrete variable in column 1 are (% of participants with risk factor present 
(level 1) in exclusions dataset (calculated from Table A.2) vs (% of participants with risk factor present in dataset used for the analyses (calculated from Table 1)), 
note for variables with more levels, vectors of incidences are presented. SD: standard deviation; WHR: waist-to-hip ratio; APOE: apolypoprotein-E; CVR: cere-
brovascular risk; WMH: white matter hyperintensity.       
Characteristics Levels (N) Mean (SD) Median (range) Missing  
Age (years) – 63.7 (7.5) 64.4 (46.6; 80.3) 0 
Sex Men (2,496), Women (2,842) – – 0 
(53% vs 53% women%)      
Head size – 1.3 (0.12) 1.3 (0.9; 1.8) 0  
Hypertension risk 0 (1,769), 1 (1,494) – – 2,075 
(46% vs 47%)      
(continued on next page) 
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Table A.3 
List of UK Biobank variables (available at http://biobank.ndph.ox.ac.uk/showcase/search.cgi used in the analysis. Data on 
APOE- status and WMH masks are not part of the catalogue.     
Data-Field 
ID 
Description Usage  
31 Sex  
34 Year of birth Age calculation 
52 Month of birth Age calculation 
20002 Non-cancel illness code, self-reported  
21000 Ethnic background  
53 Date of attending assessment centre Age calculation 
25000 Volumetric scaling from T1 head image to 
standard space 
Head size  
6138 Qualifications Years of education  
‘none of the above’ 7  
‘CSEs or equivalent’ 10  
‘O levels/GCSEs or equivalent’ 10  
‘A levels/AS levels or equivalent’ 13  
‘Other professional qualification’ 15  
‘NVQ or HNC or equivalent’ 19  
‘College or University degree’ 20  
‘Prefer not to answer’ NA  
20023 Mean time to correctly identify matches Speed of processing  
20116 Smoking status Pack years calculation 
3436 Age started smoking in current smokers  
2867 Age started smoking in former smokers  
6194 Age stopped smoking cigarettes (current 
cigar/pipe or previous cigarette smoker)  
2897 Age stopped smoking  
6183 Number of cigarettes previously smoked 
daily (current cigar/pipe smokers)  
2887 Number of cigarettes previously smoked 
daily  
2907 Ever stopped smoking for 6 + months  
3486 Ever tried to stop smoking   
6177 Medication for cholesterol, blood pressure 
or diabetes (males only) 
Cholesterolemia and  
Hypertension  
risk 
6153 Medication for cholesterol, blood pressure, 
diabetes, or take exogenous hormones 
(females only)   
2443 Diabetes diagnosed by doctor Diabetes  
4079 Diastolic blood pressure, automated 
reading 
Hypertension risk 
94 Diastolic blood pressure, manual reading  
4080 Systolic blood pressure, automated reading  
93 Systolic blood pressure, manual reading   
48 Waist circumference Waist-to-hip ratio 
49 Hip circumference  
Table A.2 (continued)      
Characteristics Levels (N) Mean (SD) Median (range) Missing  
Hypercholesterolemia 0 (4,020), 1 (1,107) – – 211 
(22% vs 20%)      
Diabetes 0 (4,932), 1 (241) – – 165 
(5% vs 5%)      
Smoking (score/pack years) 0 (1,827), 1 (340), 2 (25) 4.7 (11.3) 0 (0; 117.5) 3,146 
(83%,16%,1%) vs (83%,16%,1%)      
WHR (indicator/continuous) 0 (2,563), 1 (2,362) 0.9 (0.1) 0.9 (0.6; 1.2) 413 
(48% vs 47%)      
APOE- status 0 (3,622), 1 (1,092), 2 (110) – – 514 
(75%,23%,2%) vs (75%,23%,2%)      
WMH load (2 mm3 voxels) – 593 (732.1) 356 (3; 11,450) 0  
Reaction time* (milliseconds) – 594.3 (109.9) 577 (150; 1,445) 1,505 
Years of education 7 (468), 10 (900), 13 (330), 15 (704), 19 (946), 20 (2,752) 16.4 (4.5) 19 (7; 20) 189 
(8%,15%,5%,12%,15%,45%) vs (6%,13%,6%,12%,16%,47%)        
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Table A.4 
Mediation analysis exploring of the effect of log(WMH load) on speed of processing (reaction time) through cerebrovascular risk factors as mediator variable. Models 
(mediator and outcome) are controlled for age, sex, age-by sex interaction, years of education and head size. None of the risk factors shows a significant mediation 
effect. stands for the maximum likelihood estimate of the regression coefficient . BP: blood pressure; CI: confidence interval.         
Average effect Systolic BP (continuous) Hypertension risk (indicator)  
Estimate 95% CI p-value Estimate 95% CI p-value  
Mediation effect −0.001 (−0.004; 0.000) 0.342 −0.002 (−0.005; 0.00) 0.222 
Direct effect 0.027 (0.008; 0.050) 0.005 0.027 (0.008; 0.050) 0.005 
Total effect 0.025 (0.007; 0.040) 0.006 0.025 (0.006; 0.040) 0.009        
Proportion mediated −0.054 (−0.296; 0.070) 0.346 −0.062 (−0.346; 0.050) 0.230        
Average effect Hypercholesterolemia (indicator) Diabetes (indicator)  
Estimate 95% CI p-value Estimate 95% CI p-value 
Mediation effect 0.001 (−0.000; 0.000) 0.141 0.001 (−0.001; 0.000) 0.227 
Direct effect 0.024 (0.005; 0.040) 0.009 0.024 (0.006; 0.040) 0.012 
Total effect 0.025 (0.006; 0.040) 0.007 0.025 (0.007; 0.040) 0.010        
Proportion mediated 0.037 (−0.016; 0.170) 0.147 0.035 (−0.027; 0.160) 0.234        
Average effect Smokinga (continuous) APOE- status (indicatorb)  
Estimate 95% CI p-value Estimate 95% CI p-value 
Mediation effect −0.001 (−0.002; 0.000) 0.045 0.000 (−0.001; 0.000) 0.885 
Direct effect 0.026 (0.007; 0.050) 0.005 0.025 (0.007; 0.040) 0.009 
Total effect 0.025 (0.006; 0.040) 0.008 0.025 (0.007; 0.040) 0.010        
Proportion mediated −0.043 (−0.183; 0.000) 0.053 0.002 (−0.044; 0.060) 0.886 
a log-transformed pack years used (0.05 added to 0 pack year values); 
b APOE- status represented by 1 if homozygous ( 4/ 4), 0 otherwise.  
Fig. A.1. Significance maps (z-scores based on mean bias-reduced estimates) for APOE 4/ 4 effect compared to no 4 alleles (marginal model). Data on 13,680 UK 
Biobank individuals, and voxels with at least four individuals having a WMH explored (i.e. 0.03% WMH incidence); 5% FDR correction applied; Slices 
= = =x y z36, 25, 40 shown. 
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Fig. A.3. Mediation analysis diagram. The mediators 
explored are the six cerebrovascular risk factors. All 
models are controlled for age, sex, age-sex interac-
tion, and head size. The main interest is in whether 
the indirect effect is significant, i.e. whether the ef-
fect of the predictor X on an outcome Y operates 
through a mediator variable M (fully or partially). 
Fig. A.2. Significance maps (z-scores based on mean bias-reduced estimates) across five axial slices =z {35, 40, 45, 50, 55} in a model including age, sex, age-sex 
interaction, head size, systolic blood pressure and waist-to-hip ratio; data on 13,680 UK Biobank individuals and voxels with at least four individuals having a WMH 
explored; 5% FDR correction applied. From top to bottom each row shows z-scores for (a) Systolic BP, (b) WHR and their ‘unique’ effect, respectively, (c) ‘significant 
systolic BP/not significant WHR’ and (d) ‘not significant systolic BP/significant WHR’. BP: blood pressure; WHR: waist-to-hip ratio.. 
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Appendix B. Justification of Minimum WMH Count 
We chose a lower limit Ymin based on the following heuristic: At any one voxel, what is the smallest WMH count that can reject a null hypothesis 
of zero WMH incidence, =H p: 00 ? Of course, once a single WMH is observed we know H0 must be false, but as a heuristic it seems useful to assert 
that, if fewer than Ymin WHM are seen, we cannot even reject this obviously false H0, and this voxel should not be subject to further consideration. 
This test takes the form =z p p p N/ (1 )/ , where =p Y N/ . Solving z z for Ymin shows that to obtain a minimum significance of z requires 
+Y z N1/( 1/ )min 2 . This result is virtually independent of N, giving Y zmin 2, and for =N 13, 680 in particular, we found that =Y 4min was 
required to produce a z of at least 2, and hence we only considered voxels where 4 or more participants had a WMH.  
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